Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
P34947
UPID:
GRK5_HUMAN
Alternative names:
G protein-coupled receptor kinase GRK5
Alternative UPACC:
P34947; D3DRD0; Q5T059
Background:
G protein-coupled receptor kinase 5 (GRK5) is a serine/threonine kinase with a pivotal role in phosphorylating activated forms of GPCRs, leading to receptor desensitization, internalization, and down-regulation. It targets a wide array of GPCRs including adrenergic, muscarinic acetylcholine, dopamine, and opioid receptors. Beyond GPCRs, GRK5 phosphorylates substrates like TP53/p53, HDAC5, and ARRB1, influencing apoptosis, transcription regulation, and MAPK signaling.
Therapeutic significance:
Understanding the role of G protein-coupled receptor kinase 5 could open doors to potential therapeutic strategies.